Dr. Alon Silberman - 20 Oct 2025 Form 3 Insider Report for N2OFF, Inc. (NITO)

Reporting relationship: 10%+ Owner
Issuer ticker: NITO
Reported as of: 20 Oct 2025
Net transaction value: $0
SEC form: 3
Accepted by SEC: 28 Oct 2025, 16:05:14 UTC
Source filing: View source filing
Reporting owner signature: /s/ Dr. Alon Silberman

Key filing fact

Dr. Alon Silberman filed Form 3 for N2OFF, Inc. (NITO) on 28 Oct 2025.

Key facts

This page summarizes Dr. Alon Silberman's Form 3 filing for N2OFF, Inc. (NITO).
0 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 28 Oct 2025, 16:05.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002089463 Primary reporting owner

Silberman Alon

Relationship: 10%+ Owner
Address: 40 GORDON STREET., GIVATAYIM, ISRAEL
Signature: /s/ Dr. Alon Silberman
Signature date: 28 Oct 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NITO holding

Common Stock, par value $0.0001 per share

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 454,127
Date: 20 Oct 2025
Ownership: -Held by Altshare Trusts Ltd., of which the reporting person is the beneficiary.

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NITO holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 20 Oct 2025
Ownership: Direct
Underlying class: Restricted Stock Units
Underlying amount: 146,493
Exercise price: $0.000000
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The RSUs shall vest and convert into Shares under the following schedule: 8.33% of the Shares underlying the RSUs at the end of each three-month period following the Vesting Commencement Date, over the course of 3 years; provided, in each case, that the Grantee remains continuously as a Service Provider of the Company or its Affiliates throughout each such vesting date.